Assessment of Mendelian and risk factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening

authors

  • Nicolas Gael
  • Zarea Aline
  • Lacour Morgane
  • Quenez Olivier
  • Rousseau Stephane
  • Richard Anne-Claire
  • Bonnevalle Antoine
  • Schramm Catherine
  • Olaso Robert
  • Sandron Florian
  • Boland Anne
  • Deleuze Jean-Francois
  • Andriuta Daniela
  • Anthony Pierre
  • Auriacombe Sophie
  • Balageas Anna-Chloe
  • Ballan Guillaume
  • Barbay Melanie
  • Bejot Yannick
  • Belliard Serge
  • Benaiteau Marie
  • Bennys Karim
  • Bombois Stephanie
  • Boutoleau-Bretonniere Claire
  • Branger Pierre
  • Carlier Jasmine
  • Cartz-Piver Leslie
  • Cassagnaud Pascaline
  • Ceccaldi Mathieu-Pierre
  • Chauvire Valerie
  • Chen Yaohua
  • Cogez Julien
  • Cognat Emmanuel
  • Contegal-Callier Fabienne
  • Corneille Lea
  • Couratier Philippe
  • Cretin Benjamin
  • Crinquette Charlotte
  • Dauriat Benjamin
  • Dautricourt Sophie
  • de la Sayette Vincent
  • de Liege Astrid
  • Deffond Didier
  • Demurger Florence
  • Deramecourt Vincent
  • Derollez Celine
  • Dionet Elsa
  • Doco Fenzy Martine
  • Dumurgier Julien
  • Dutray Anais
  • Etcharry-Bouyx Frederique
  • Formaglio Maite
  • Gabelle Audrey
  • Gainche-Salmon Anne
  • Godefroy Olivier
  • Graber Mathilde
  • Gregoire Chloe
  • Grimaldi Stephan
  • Gueniat Julien
  • Gueriot Claude
  • Guillet-Pichon Virginie
  • Haffen Sophie
  • Hanta Cezara-Roxana
  • Hardy Clemence
  • Hautecloque Geoffroy
  • Heitz Camille
  • Hourregue Claire
  • Jonveaux Therese
  • Jurici Snejana
  • Koric Lejla
  • Krolak-Salmon Pierre
  • Lagarde Julien
  • Lanoiselee Helene-Marie
  • Laurens Brice
  • Le Ber Isabelle
  • Le Guyader Gwenael
  • Leblanc Amelie
  • Lebouvier Thibaud
  • Levy Richard
  • Lippi Anais
  • Mackowiak Marie-Anne
  • Magnin Eloi
  • Marelli Cecilia
  • Martinaud Olivier
  • Maureille Aurelien
  • Migliaccio Raffaella
  • Milongo-Rigal Emilie
  • Mohr Sophie
  • Mollion Helene
  • Morin Alexandre
  • Nivelle Julia
  • Noiray Camille
  • Olivieri Pauline
  • Paquet Claire
  • Pariente Jeremie
  • Pasquier Florence
  • Perron Alexandre
  • Philippi Nathalie
  • Planche Vincent
  • Pouclet-Courtemanche Helene
  • Rafiq Marie
  • Rollin-Sillaire Adeline
  • Roue-Jagot Carole
  • Saracino Dario
  • Sarazin Marie
  • Sauvee Mathilde
  • Sellal Francois
  • Teichmann Marc
  • Thauvin Christel
  • Thomas Quentin
  • Tisserand Camille
  • Turpinat Cedric
  • van Damme Laurene
  • Vercruysse Olivier
  • Villain Nicolas
  • Wagemann Nathalie
  • Charbonnier Camille
  • Wallon David

keywords

  • Alzheimer disease
  • Risk variant
  • Pathogenic variant
  • Exome
  • Clinical utility

document type

ART

abstract

Purpose: To assess the likely pathogenic/pathogenic (LP/P) variants rates in Mendelian dementia genes and the moderate-to-strong risk factors rates in patients with Alzheimer disease (AD). Methods: We included 700 patients in a prospective study and performed exome sequencing. A panel of 28 Mendelian and 6 risk-factor genes was interpreted and returned to patients. We built a framework for risk variant interpretation and risk gradation and assessed the detection rates among early-onset AD (EOAD, age of onset (AOO) ≤65 years, n = 608) depending on AOO and pedigree structure and late-onset AD (66 < AOO < 75, n = 92). Results: Twenty-one patients carried a LP/P variant in a Mendelian gene (all with EOAD, 3.4%), 20 of 21 affected APP, PSEN1, or PSEN2. LP/P variant detection rates in EOAD ranged from 1.7% to 11.6% based on AOO and pedigree structure. Risk factors were found in 69.5% of the remaining 679 patients, including 83 (12.2%) being heterozygotes for rare risk variants, in decreasing order of frequency, in TREM2, ABCA7, ATP8B4, SORL1, and ABCA1, including 5 heterozygotes for multiple rare risk variants, suggesting non-monogenic inheritance, even in some autosomal-dominant-like pedigrees. Conclusion: We suggest that genetic screening should be proposed to all EOAD patients and should no longer be prioritized based on pedigree structure.

more information